SUILANE COELHO RIBEIRO OLIVEIRA
Projetos de Pesquisa
Unidades Organizacionais
7 resultados
Resultados de Busca
Agora exibindo 1 - 7 de 7
bookPart Câncer anal(2017) NAHAS, Caio Sergio Rizkallah; OLIVEIRA, Suilane Coelho Ribeiro; GIL, Erlon; NAHAS, Sergio Carlos- Phase II study of capecitabine in substitution of 5-FU in the chemoradiotherapy regimen for patients with squamous cell carcinoma of the anal canal.(2012) RIBEIRO, Suilane Coelho; VENCHIARUTTI, Camila; RIECHELMANN, Rachel; GIL, Erlon; NAHAS, Caio; COUDRY, Renata; FREITAS, Daniela; SARAGIOTTO, Daniel F.; ARRUDA, Fernando; AZAMBUJA, Rodrigo; HOFF, Paulo
- Prospective study of biomarkers in squamous cell carcinoma of the anal canal (SCCAC) and their influence on treatment outcomes: Final results.(2017) MONIZ, Camila Motta Venchiarutti; RIECHELMANN, Rachel Pimenta; RIBEIRO, Suilane Coelho; RIVELLI, Thomas Giollo; BARIANI, Giovanni Mendonca; CHEN, Andre; FRANCO, Rejane; NAHAS, Caio; PEREIRA, Allan Andresson Lima; ORTEGA, Cintia; SABBAGA, Jorge; MEIRELES, Sibele; COUDRY, Renata A.; HOFF, Paulo Marcelo
- Squamous-cell carcinoma of the anal canal: Room for improvement with targeted therapy(2012) OLIVEIRA, Suilane; TEIXEIRA, Luis; HOFF, Paulo M.; GRAMONT, Aimery De; TOURNIGAND, ChristopheCarcinoma of the anal canal is a rare disease accounting for 1-5% of gastrointestinal tract malignancies. However, its incidence is increasing worldwide. Chemoradiation is the standard treatment for most patients with squamous-cell carcinoma of the anal canal and was first described by Nigro et al. Since then, no other effective treatment was developed. Patients with metastatic disease should be considered candidates for clinical trials. New treatment strategies, including molecular target therapies, are warranted in order to improve disease control. Despite the rarity of this disease, it is urgent to improve its treatment by introducing targeted therapy in the arena.
- The expression profile of biomarkers in squamous cell carcinoma of the anal canal and their influence on treatment outcomes: Preliminary results(2016) MONIZ, Camila Motta Venchiarutti; RIECHELMANN, Rachel Pimenta; RIBEIRO, Suilane Coelho; BARIANI, Giovanni Mendonca; RIVELLI, Thomas Giollo; ORTEGA, Cintia; PEREIRA, Allan Andresson Lima; MEIRELES, Sibele Inacio; CHEN, Andre; NAHAS, Caio; SABAGGA, Jorge; COUDRY, Renata A.; HOFF, Paulo Marcelo
bookPart 0 Citação(ões) na Scopus Integration of anti-vascular endothelial growth factor therapies with cytotoxic chemotherapy in the treatment of colorectal cancer(2012) OLIVEIRA, S. C. R.; MACHADO, K. K.; SABBAGA, J.; HOFF, P. M.conferenceObject Phase II study of capecitabine in substitution of 5-FU in the chemoradiotherapy regimen for patients with squamous cell carcinoma of the anal canal(2014) RIBEIRO, Suilane Coelho; MONIZ, Camila Motta Venchiarutti; RIECHELMANN, Rachel; BARIANI, Giovanni Mendonca; BRAGHIROLI, Maria Ignez; NAHAS, Caio; COUDRY, Renata; ALEX, Alexandra Khichfy; CARNEIRO, Allyne Q.; NEBULONI, Daniela R.; GLASBERG, Joao; HOFF, Paulo